| Date |
Title |
Rating |
| 2008-09-29 |
A control dashboard for the pharmaceuticals industry |
None |
| 2008-09-29 |
Arana files U.S. IND for lead anti-Inflammatory |
None |
| 2008-09-29 |
Senate passes bill to aid low-income seniors pay Medicare premiums |
None |
| 2008-09-29 |
Average monthly premium for stand-alone Medicare prescription drug coverage will increase by 24% in 2009 to $37, according to report |
None |
| 2008-09-29 |
PEPFAR suspends funding for three Ranbaxy AIDS drugs banned by FDA |
None |
| 2008-09-25 |
CytRx to present new data on molecular chaperone drug discovery technology |
None |
| 2008-09-22 |
House members send letter to Condoleezza Rice requesting information on antiretrovirals supplied to PEPFAR by Ranbaxy |
None |
| 2008-09-22 |
Pharmacy benefits managers promote low-cost generics, adherence to drug plans |
None |
| 2008-09-22 |
Utah preferred prescription drug list savings less than projected |
None |
| 2008-09-22 |
Supreme Court prepares to hear pre-emption case that could give pharmaceutical companies protection against liability |
None |
| 2008-09-22 |
Advisers to Presidential candidates discuss positions on reimportation, generics, biotechnology medications |
None |
| 2008-09-22 |
Brazil to produce generic version of Merck's antiretroviral Efavirenz |
None |
| 2008-09-18 |
Review of drug delivery market |
5 |
| 2008-09-16 |
GlaxoSmithKline and XenoPort submit NDA for Solzira for restless legs syndrome |
None |
| 2008-09-16 |
Mylan receives FDA approval for generic version of Risperdal |
None |
| 2008-09-16 |
AIDS Healthcare Foundation says "shame on Abbott" |
None |
| 2008-09-16 |
FDA warns Ranbaxy Labs and issues import alert |
None |
| 2008-09-16 |
CMS to suspend competitive acquisition program for medications covered under Medicare Part B |
None |
| 2008-09-16 |
FDA grants priority review status to Novartis' ACT Coartem |
None |
| 2008-09-15 |
FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP |
None |
| 2008-09-15 |
Pathways to clinical goals speeds cancer therapy approval |
None |
| 2008-09-15 |
European disparities in access to cancer drugs |
None |
| 2008-09-15 |
Lawmakers warn federal officials to fix problems with Medicare information phone line |
None |
| 2008-09-15 |
New cannabis-like drugs could block pain without affecting brain |
None |
| 2008-09-15 |
Keppra XR approved in the U.S. for partial onset seizures |
None |
| 2008-09-14 |
FDA approves expanded uses for Gardasil for vaginal and vulvar cancer caused by HPV |
None |
| 2008-09-14 |
FDA approves Gamunex for chronic inflammatory demyelinating polyneuropathy |
1 |
| 2008-09-11 |
Untapped potential of antidepressants for cancer |
None |
| 2008-09-11 |
Starpharma, SSL International reach marketing agreement over VivaGel condoms |
None |
| 2008-09-10 |
Schering-Plough launches Bridion (sugammadex) in Europe |
None |
| 2008-09-10 |
AP/Houston Chronicle examines telepharmacies in North Dakota |
None |
| 2008-09-10 |
Counterfeit drugs for malaria, other diseases threaten public health, WHO Director-General Chan says |
None |
| 2008-09-10 |
The Hill examines Presidential candidates' positions on prescription drug issues |
None |
| 2008-09-10 |
GlaxoSmithKline and Cellzome announce major strategic alliance |
None |
| 2008-09-09 |
Pfizer to withdraw global marketing applications for Dalbavancin to conduct a new trial |
None |
| 2008-09-09 |
Supreme Court to consider whether to bar liability lawsuits against pharmaceutical companies |
None |
| 2008-09-09 |
FDA posts names of prescription drugs being investigated for potential safety problems |
None |
| 2008-09-09 |
VivaGel coated condoms - Starpharma and SSL International in business |
None |
| 2008-09-08 |
Orexo and Boehringer Ingelheim extend collaboration |
None |
| 2008-09-07 |
About 85% of insurers' marketing materials for prescription drug plans do not meet Medicare guidelines, audit finds |
None |
| 2008-09-07 |
Simple hardness test detects fake medicines |
None |
| 2008-09-07 |
FDA to post quarterly report of potential drug safety issues |
None |
| 2008-09-07 |
Free drug samples may end up costing uninsured more |
None |
| 2008-09-05 |
FDA forces manufacturers of TNF-blockers to highlight risk of fungal infections |
None |
| 2008-09-04 |
Nanotherapeutics files INDA for NanoDOX hydrogel to treat type of diabetic ulcers |
None |
| 2008-09-04 |
Unsuccessful drug against anxiety opens a novel gateway for the treatment of cancer |
1 |
| 2008-09-04 |
FDA 'fast track' granted to BioMS Medical for lead drug, dirucotide for the treatment of multiple sclerosis |
None |
| 2008-09-04 |
FDA assigns priority review to ATryn from GTC Biotherapeutics |
None |
| 2008-09-04 |
Celgene receives FDA 'fast track' for Amrubicin in small cell lung cancer after first-line chemotherapy |
None |
| 2008-09-04 |
Anadis to commercialise "BioGard" adjunctive therapy for HIV/AIDS |
None |
| 2008-09-04 |
Merck Serono and Ablynx to jointly develop nanobodies |
None |
| 2008-09-03 |
Vimpat (lacosamide) approved in Europe |
None |
| 2008-09-03 |
Biovail files abbreviated new drug application for Fenofibrate tablets |
None |
| 2008-09-03 |
Concern raised again about heart drugs Zetia and Vytorin |
None |
| 2008-09-02 |
Spinifex secures major investment to develop pain drug |
None |
| 2008-09-01 |
Economic pressures lead some uninsured to stop medications, cut doses |
None |
| 2008-09-01 |
WSJ examines drugmakers' use of 'unbranded product advertising' to promote disease awareness, treatment options |
None |
| 2008-09-01 |
Antiangiogenic and anti-inflammatory drugs: are they safe? |
None |